(Q41920359)

14 October 2017

title

Antimalarial drugs for rheumatoid arthritis (English)

1 reference

14 October 2017

0 references

A. H. Mackenzie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6362406

8 October 2023

language of work or name

English

0 references

publication date

1 December 1983

1 reference

14 October 2017

30 December 1983

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6362406

full work available at URL

8 October 2023

https://api.elsevier.com/content/article/PII:0002934383904746?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

https://api.elsevier.com/content/article/PII:0002934383904746?httpAccept=text/plain

8 October 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

American Journal of Medicine

8 October 2023

published in

1 reference

14 October 2017

volume

75

1 reference

14 October 2017

issue

6A

1 reference

14 October 2017

page(s)

48-58

1 reference

Antimalarials in the management of discoid and systemic lupus erythematosus

14 October 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Azathioprine in early rheumatoid arthritis. Comparison with gold and chloroquine

8 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

An appraisal of chloroquine

8 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Chloroquine retinopathy in patients with rheumatoid arthritis

8 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Analysis of treatment terminations with gold and antimalarial compounds in rheumatoid arthritis

8 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

8 October 2023

Chloroquine: a review

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Chloroquine-induced ocular toxicity

8 October 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Is chloroquine obsolete in treatment of rheumatic disease?

8 October 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Ophthalmological safety of chloroquine

8 October 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Chloroquine: ophthalmological safety, and clinical assessment in rheumatoid arthritis

8 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Ophthalmologic safety of long-term hydroxychloroquine treatment

8 October 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Chloroquine retinopathy. Early detection by retinal threshold test

8 October 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Electro-oculogram findings in patients treated with antimalarial drugs

8 October 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Delayed Onset of Chloroquine Retinopathy

8 October 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Long-Term Course of Chloroquine Retinopathy after Cessation of Medication

8 October 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Ocular Changes Induced by Long-Term Hydroxychloroquine (Plaquenil) Therapy

8 October 2023

28

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Antimalarial drugs-350 years

8 October 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Prognosis in rheumatoid arthritis. A longitudinal study of newly diagnosed younger adult patients

8 October 2023

30

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

An unusual reaction to chloroquine-primaquine

8 October 2023

31

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Comparison of effects of two antimalarial agents, hydroxychloroquine sulfate and chloroquine phosphate, in patients with rheumatoid arthitis.

8 October 2023

33

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Chloroquine in rheumatoid arthritis; a double blindfold trial of treatment for one year

8 October 2023

36

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Chloroquine diphosphate in rheumatoid arthritis. A controlled trial

8 October 2023

37

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

A controlled study of chloroquine as an antirheumatic agent

8 October 2023

38

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Hydroxychloroquine sulfate ("plaguenil") in treatment of rheumatoid arthritis

8 October 2023

40

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

AMOPYROQUIN (PROPOQUIN) IN RHEUMATOID ARTHRITIS

8 October 2023

41

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Antimalarial Treatment of Rheumatoid Arthritis

8 October 2023

42

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Pharmacokinetics of antimalarials and proposals for dosage regimens

8 October 2023

44

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Effect of gold salts and antimalarials on the rheumatoid factor in rheumatoid arthritis

8 October 2023

45

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Chloroquine retinopathy: is there a safe daily dose?

8 October 2023

47

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Dosage of Antimalarial Drugs for Children with Juvenile Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Clinical Study with Determination of Serum Concentrations of Chloroquine and Hydroxychloroquine

8 October 2023

48

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Chloroquine treatment in rheumatoid arthritis. Correlation of clinical response to plasma protein changes and chloroquine levels

8 October 2023

54

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Action of chloroquine phosphate in rheumatoid arthritis. II. Chromosome damaging effect

8 October 2023

58

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Chloroquine inhibition of repair of DNA damage induced in mammalian cells by methyl methanesulfonate

8 October 2023

59

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Enhancement of the radiation response of cultured tumor cells by chloroquine

8 October 2023

60

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Action of chloroquine phosphate in rheumatoid arthritis. 1. Immunosuppressive effect

8 October 2023

63

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

LYSOSOMES IN DIVIDING CELLS, WITH SPECIAL REFERENCE TO LYMPHOCYTES

8 October 2023

64

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Lysosomes, pH and the Anti-malarial Action of Chloroquine

8 October 2023

65

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Inactivation of lysosomal function in normal cultured human fibroblasts by chloroquine

8 October 2023

66

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Biochemical lesion in chloroquine intoxication

8 October 2023

68

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

The chemosuppression of chemotaxis

8 October 2023

69

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

The effect of immunosuppressive and anti-inflammatory drugs on monocyte function in vitro

8 October 2023

70

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Autophagic vacuoles produced in vitro. II. Studies on the mechanism of formation of autophagic vacuoles produced by chloroquine

8 October 2023

71

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Differences in the retinotoxic action of chloroquine and phenothiazine derivatives

8 October 2023

72

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Commentary. Lysosomotropic agents

8 October 2023

73

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Interactions of chloroquine with different glycerophospholipids

8 October 2023

74

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Evidence that coated vesicles isolated from brain are calcium-sequestering organelles resembling sarcoplasmic reticulum

8 October 2023

75

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Coated vesicles: characterization, selective dissociation, and reassembly

8 October 2023

76

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Clathrin-coated vesicles: Isolation, dissociation and factor-dependent reassociation of clathrin baskets

8 October 2023

78

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Effects of chloroquine and 4,4'-bis(diethylaminoethoxy)α,β-diethyldiphenylethane on the incorporation of [3H]glycerol into the phospholipids of rat liver lysosomes and other subcellular fractions, in vivo

8 October 2023

79

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Chloroquine inhibits lysosomal enzyme pinocytosis and enhances lysosomal enzyme secretion by impairing receptor recycling

8 October 2023

80

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Chloroquine and ammonium ion inhibit receptor-mediated endocytosis of mannose-glycoconjugates by macrophages: apparent inhibition of receptor recycling

8 October 2023

81

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

SUPPRESSION OF IN VITRO LYMPHOCYTE RESPONSES BY CHLOROQUINE.

8 October 2023

82

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents

8 October 2023

84

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Effect of Chloroquine on Morphology of Cytoplasmic Granules in Maturing Human Leukocytes—an Ultrastructural Study*

8 October 2023

85

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

In vitro inhibition of protein synthesis in the retinal pigment epithelium by chloroquine

8 October 2023

88

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

STUDIES ON THE CHRONIC TOXICITY OF CHLOROQUINE (SN-7618)

8 October 2023

89

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Studies on the chemotherapy of the human malarias; of the human malarias the physiological disposition, antimalarial activity, and toxicity of several derivatives of 4-aminoquinoline

8 October 2023

91

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

EFFECT OF CHLOROQUINE ON THE SULFHYDRYL GROUP AND THE DENATURATION OF BOVINE SERUM ALBUMIN.

8 October 2023

92

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Absorption of antimalarial drugs in human skin; spectroscopic and chemical analysis in epidermis and corium

8 October 2023

94

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Studies on the mechanism of drug-binding to melanin

8 October 2023

98

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Ophthalmological examination of patients taking chloroquine

8 October 2023

99

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

In vitro action of chloroquine on nucleic acid and protein biosynthesis in the rabbit retina

8 October 2023

100

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Chloroquine phosphate (Aralen) in the long-term treatment of rheumatoid arthritis

8 October 2023

101

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Chloroquine: mechanism of action

8 October 2023

103

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Immunophagocytic properties of retinal pigment epithelium cells

8 October 2023

105

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

Experimentally Induced Chloroquine Retinopathy in Rabbits

8 October 2023

107

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

The Molecular Basis of the Action of Chloroquine in Porphyria Cutanea Tarda

8 October 2023

112

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90474-6

8 October 2023

Identifiers

1 reference

14 October 2017

1 reference